| Literature DB >> 31661905 |
Meijin Du1,2, Dan Zhang3, Yilin Hou4,5, Xiaohui Zhao6,7, Yu Li8,9.
Abstract
In this paper, two-dimensional quantitative structure-activity relationship (2D-QSAR) and principal component analysis (PCA) methods were employed to screen the main parameters affecting the genotoxicity of fluoroquinolones (FQs), and the rules affecting the genetic toxicity of FQs were investigated by combining 2D-QSAR and PCA with the sensitivity analysis method. First, four types of parameters were calculated, namely, the geometric parameters (7), electronic parameters (5), physical and chemical parameters (8), and spectral parameters (7), but the physical and chemical parameters heat of formation (HF) and critical volume (CV) were excluded after the establishment of the 2D-QSAR model. Then, after PCA, it was found that the first principal component represented the main driving factors affecting the molecular genetic toxicity of FQs. In addition, after comprehensive analysis of the factor loading of the first, second, and third principal components, seven parameters affecting the genotoxicity of the FQs were screened out, namely, total energy (TE), critical temperature (CT), and molecular weight (Mol Wt) (increased with increasing genotoxicity of the FQs) and steric parameter (MR), quadrupole moment QXX (QXX), quadrupole moment QYY (QYY), and boiling point (BP) (decreased with increasing genotoxicity of the FQs); the above key parameters were also verified by sensitivity analysis. The obtained rules could be used to determine the substitution sites and the substitution groups associated with higher genotoxicity in the process of FQ modification, and these rules agreed well with the hologram quantitative structure-activity relationship (HQSAR) model. Finally, it was also found through SPSS analysis that the parameters screened in this paper were significantly correlated with FQ derivatives' genetic toxicity.Entities:
Keywords: 2D-QSAR model; fluoroquinolone molecules; genotoxicity; molecular design; principal component analysis; sensitivity analysis
Mesh:
Substances:
Year: 2019 PMID: 31661905 PMCID: PMC6862474 DOI: 10.3390/ijerph16214156
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Geometric parameter, electronic parameter, physical and chemical parameter, and spectral parameter factor loading of fluoroquinolones (FQs).
| Parameters | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 |
|---|---|---|---|---|---|---|---|---|
| TE (aU) | −0.828 | 0.208 | 0.118 | 0.113 | 0.012 | 0.266 | 0.003 | 0.155 |
| q+ (e) | −0.324 | −0.617 | 0.196 | 0.543 | −0.07 | 0.145 | −0.249 | −0.178 |
| q− (e) | −0.328 | 0.43 | −0.127 | 0.693 | 0.17 | 0.079 | −0.057 | 0.111 |
| 0.086 | 0.633 | 0.205 | −0.072 | 0.095 | 0.563 | 0.063 | 0.375 | |
| EG (eV) | −0.068 | 0.626 | 0.139 | 0.024 | −0.221 | 0.229 | 0.218 | −0.461 |
| PF (cm−1) | 0.215 | 0.26 | 0.49 | −0.283 | 0.073 | 0.526 | 0.113 | −0.144 |
| QXX (Debye·Å) | −0.888 | −0.032 | −0.084 | 0.137 | −0.184 | −0.03 | 0.183 | 0.013 |
| QYY (Debye·Å) | −0.885 | −0.181 | 0.027 | −0.233 | −0.169 | 0.143 | −0.085 | 0.032 |
| QZZ (Debye·Å) | −0.174 | −0.057 | 0.225 | 0.122 | 0.499 | −0.267 | 0.657 | 0.073 |
| QXY (Debye·Å) | 0.116 | −0.432 | −0.169 | −0.205 | 0.572 | 0.136 | −0.469 | −0.015 |
| QYZ (Debye·Å) | −0.003 | −0.467 | −0.005 | −0.324 | 0.688 | −0.043 | −0.022 | 0.164 |
| BP (K) | 0.853 | −0.288 | 0.265 | 0.039 | −0.062 | 0.01 | −0.02 | −0.148 |
| MP (K) | 0.585 | −0.465 | 0.487 | 0.037 | −0.253 | 0.039 | 0.004 | −0.076 |
| CT (K) | 0.827 | −0.221 | 0.382 | 0.147 | 0.008 | −0.039 | −0.094 | 0.069 |
| GE (kJ/mol) | −0.224 | 0.036 | 0.735 | 0.124 | 0.105 | −0.17 | −0.275 | 0.283 |
| logP | 0.594 | −0.051 | −0.154 | 0.288 | 0.385 | 0.099 | 0.224 | −0.08 |
| MR (cm3/mol) | 0.947 | 0.161 | 0.162 | 0.077 | 0.089 | 0.089 | −0.071 | 0.055 |
| HL | −0.372 | −0.403 | 0.659 | 0.317 | 0.085 | −0.054 | −0.112 | −0.223 |
| Mol Wt | 0.97 | 0.039 | −0.044 | 0.046 | −0.032 | 0.003 | 0.038 | −0.048 |
| IR-(C–O)svf (cm−1) | −0.178 | 0.796 | 0.352 | −0.053 | 0.231 | −0.229 | −0.078 | −0.249 |
| IR-brbvf (cm−1) | −0.22 | −0.404 | 0.049 | 0.602 | 0.187 | 0.452 | 0.09 | −0.073 |
| IR-mbvf (cm−1) | −0.039 | −0.498 | 0.608 | −0.135 | −0.087 | −0.194 | 0.414 | 0.136 |
| Raman-(C–O)svf (cm−1) | −0.068 | 0.778 | 0.362 | 0.045 | 0.075 | −0.401 | −0.172 | −0.013 |
| Raman-brsvf (cm−1) | 0.478 | 0.497 | −0.05 | 0.278 | −0.188 | −0.24 | −0.167 | 0.003 |
| Raman-msvf (cm−1) | 0.432 | 0.066 | −0.07 | 0.426 | −0.341 | −0.049 | 0.056 | 0.521 |
| Eigenvalue | 7.992 | 5.066 | 2.887 | 2.166 | 1.941 | 1.516 | 1.244 | 1.038 |
| Contribution rate % | 28.54 | 18.09 | 10.31 | 7.74 | 6.93 | 5.42 | 4.44 | 3.71 |
| Cumulative contribution rate % | 28.54 | 46.64 | 56.95 | 64.68 | 71.62 | 77.03 | 81.48 | 85.18 |
Note: TE: total energy; q+: the most positive atomic partial Mulliken charge; q−: the most negative atomic partial Mulliken charge; ELUMO: the lowest unoccupied molecular orbital energy; EG: energy gap; PF: positive frequency; QXX: quadrupole moment QXX; QYY: quadrupole moment QYY; QZZ: quadrupole moment QZZ; QXY: quadrupole moment QXY: QYZ: quadrupole moment QYZ; BP: boiling point; MP: melting point; HL: Henry’s law constant; Mol Wt: molecular weight; IR-(C–O)svf: IR C–O stretching vibration frequency; IR-brbvf: IR benzene ring breathing vibration frequency; IR-mbvf: IR molecular breathing vibration frequency; Raman-(C–O)svf: Raman C–O stretching vibration frequency; Raman-brsvf: Raman benzene ring breathing vibration frequency; Raman-msvf: Raman molecular breathing vibration frequency.
Figure 1Scree plot of FQ parameters.
Calculation of the sensitivity coefficient of the independent variables (parameters) in the two-dimensional quantitative structure–activity relationship (2D-QSAR) model.
| Parameter | 10% | 20% | 30% | 40% | 50% |
|---|---|---|---|---|---|
| TE (aU) | −6.1400 | −15.1579 | 62.3985 | 11.5861 | 6.7924 |
| q+ (e) | −5.7542 | −15.2817 | 93.7658 | 11.2650 | 6.8956 |
| q− (e) | 0.9945 | 0.9950 | 0.9954 | 0.9957 | 0.9960 |
| 2.7980 | 2.4334 | 2.1917 | 2.0198 | 1.8912 | |
| EG (eV) | 5.5865 | 4.5002 | 3.3751 | 3.0462 | 2.6025 |
| PF (cm−1) | −0.2641 | −0.2951 | −0.3278 | −0.3622 | −0.3984 |
| QXX (Debye·Å) | 0.4538 | 0.4755 | 0.4955 | 0.5140 | 0.5312 |
| QYY (Debye·Å) | −2.6409 | −3.7918 | −6.0044 | −12.0210 | −90.9575 |
| QZZ (Debye·Å) | −0.0180 | −0.0197 | −0.0214 | −0.0230 | −0.0247 |
| QXY (Debye·Å) | −0.0275 | −0.0301 | −0.0327 | −0.0353 | −0.0379 |
| QYZ (Debye·Å) | −0.0176 | −0.0193 | −0.0210 | −0.0227 | −0.0245 |
| BP (K) | 35.0316 | 9.1324 | 5.6180 | 4.2245 | 3.4770 |
| MP (K) | −2.4720 | −3.4785 | −5.3066 | −9.6565 | −33.3486 |
| CT (K) | 9.0000 | 5.4000 | 4.0345 | 3.3158 | 2.8723 |
| GE (kJ/mol) | −0.1507 | −0.1667 | −0.1831 | −0.2000 | −0.2174 |
| log | 0.2299 | 0.2456 | 0.2608 | 0.2753 | 0.2893 |
| MR (cm3/mol) | 21.4571 | 7.9357 | 5.1740 | 3.9862 | 3.3241 |
| HL | 1.0656 | 1.0598 | 1.0550 | 1.0508 | 1.0473 |
| Mol Wt | 7.2162 | 4.7536 | 3.6888 | 3.0944 | 2.7153 |
| IR-(C–O)svf (cm−1) | −4.0549 | −7.0062 | −18.2386 | 48.7423 | 11.6530 |
| IR-brbvf (cm−1) | −1.4838 | −1.8711 | −2.4015 | −3.1722 | −4.3945 |
| IR-mbvf (cm−1) | −0.9196 | −1.0947 | −1.3049 | −1.5621 | −1.8839 |
| Raman-(C–O)svf (cm−1) | −3.2035 | −4.9392 | −9.0428 | −32.1439 | 26.4899 |
| Raman-brsvf (cm−1) | −0.7395 | −0.8656 | −1.0101 | −1.1803 | −1.3803 |
| Raman-msvf (cm−1) | 0.3564 | 0.3765 | 0.3956 | 0.4133 | 0.4302 |
Figure 2Genotoxicity sensitivity coefficient of FQ parameters.
Figure 3Amifloxacin (AMI), balofloxacin (BAL), cinoxacin (CIN), fleroxacin (FLE), pazufloxacin (PAZ), and rufloxacin (RUF) molecular structures and modified substitution sites.
The structure and main parameters of CIN molecular derivatives.
| Compound | Structure | MR (cm−3/mol) | QXX (Debye·Å) | QYY (Debye·Å) | BP (K) | Mol Wt | TE (aU) | CT (K) | pLOEC | ΔpLOEC |
|---|---|---|---|---|---|---|---|---|---|---|
| CINN 1 |
| 84.38 | −158.28 | −123.36 | 955.4 | 302.33 | −1027.08 | 961.98 | 7.837 | 1.317 |
| CINN 2 |
| 94.22 | −182.41 | −136.16 | 960.78 | 330.38 | −1105.71 | 957.05 | 8.611 | 2.091 |
| CINN 3 |
| 89.07 | −168.43 | −132.4 | 973.61 | 316.35 | −1066.41 | 966.16 | 8.006 | 1.486 |
| CINN 4 |
| 86.61 | −163.89 | −130.37 | 1017.24 | 317.34 | −1086.28 | 961.41 | 7.939 | 1.419 |
| CINN 5 |
| 93.76 | −149.72 | −139.78 | 991.82 | 330.38 | −1105.73 | 970.94 | 7.993 | 1.473 |
| CINN 6 |
| 90.77 | −148.17 | −137.17 | 1018.91 | 328.37 | −1104.48 | 969.46 | 8.56 | 2.04 |
Figure 4The variation trend of CIN molecular derivative parameters and their genotoxicity.
The parameters and genotoxicity values of five tautomeric forms.
| Structures | Parameters | Genotoxicity Values | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mol Wt | BP (K) | CT (K) | MR | TE (aU) | QXX (Debye·Å) | QYY (Debye·Å) | 2D-QSAR | HQSAR | Degree of Change (%) | |
|
| 332.35 | 987.79 | 965.51 | 90.78 | −1148.32 | −17.0258 | 10.1843 | 4.0635 | 4.3154 | 5.84 |
|
| 320.34 | 958.27 | 948.57 | 88.37 | −1110.25 | −17.9215 | 9.0487 | 4.2216 | 4.6281 | 8.78 |
|
| 352.15 | 980.63 | 949.98 | 93.46 | −1248.79 | −15.0983 | 5.6736 | 4.9677 | 5.2607 | 5.57 |
|
| 334.16 | 940.67 | 938.98 | 93.41 | −1149.56 | −19.7039 | 10.1977 | 4.7043 | 5.0496 | 6.84 |
|
| 390.43 | 1080.78 | 999.32 | 107.12 | −1341.44 | −9.4622 | 5.3841 | 4.5417 | 4.9107 | 7.51 |